Introduction
The bacteria, fungi, protozoa, and viruses that inhabit the gastrointestinal tract combine to comprise the host's intestinal microbiota and are integral to digestive and metabolic processes necessary for general health. The bacterial component of the microbiota is the most well defined and studied. A large degree of diversity of bacterial species is found throughout the intestine, with the lowest total concentration of microbes found in the duodenum and steadily increasing until the peak density of 10 11 -10 12 cfu/ml of luminal content in the proximal large intestine [1, 2] . Nonculture-based methods have expanded the ability to identify individual bacterial species with current estimates of total diversity between 15 000 and 36 000 individual species inhabiting the human intestine [3] . The majority of these bacteria belong to the Bacteroidetes ($64%) and Firmicutes ($23%) phyla, with other communities from the Proteobacteria and Actinobacteria phyla.
Alterations in the composition of the intestinal microbiota have been linked with several human diseases. The occurrence of obesity in both mice and humans has been associated with a decrease in the frequency of Bacteroidetes and an increase among Firmicutes. The shift in the Bacteroidetes/Firmicutes ratio increases the ability of the microbiota to break down indigestible fiber into shortchain fatty acids (SCFAs), thus providing an additional energy source that is capable of being converted into fat [4] [5] [6] . In addition to obesity, clinical evidence has linked the microbiota to the unregulated immune responses observed in diseases such Crohn's disease, ulcerative colitis, and coeliac disease [7] [8] [9] [10] [11] [12] [13] . These chronic inflammatory diseases are associated with decreased species diversity within the patient's microbiota and aberrant immune responses to bacteria found within the intestine, including lymphocyte activation and proinflammatory cytokine secretion [14] [15] [16] [17] [18] [19] [20] . Furthermore, reduction in the intestinal microbiota via antibiotics or diversion of the fecal stream away from the inflamed portion of the intestine has been moderately successful in treating Crohn's disease, thus strengthening the link between the microbiota and intestinal inflammation [21] [22] [23] [24] .
Perturbations of the intestinal microbiota have also been linked to dysregulated immune responses and inflammatory diseases at peripheral tissue sites distal from the intestine [25] . For example, there is a strong correlation between treating infants with multiple rounds of antibiotics and the development of asthma [26, 27] . The presence of particular bacterial species such as Bifidobacterium pseudocatenulatum, Clostridium difficile, and Escherichia coli is associated with increased cases of eczema [25, 28, 29] . Because of the correlation between altered microbiota and inflammatory diseases, administration of 'probiotic' bacterial species has been employed to prevent or ameliorate certain atopic and intestinal inflammatory diseases [30] [31] [32] [33] [34] . Despite encouraging results, the full potential of probiotic therapy may not be realized without a clearer understanding of the mechanisms through which the microbiota interact with and shape the immune system. This review will focus on the progress that has been made in identifying specific microbial signals that shape mammalian immune cell homeostasis.
Altered microbiota influence immune cell homeostasis: lessons from murine model systems
Mouse models enable the manipulation of the intestinal microbiota and systematic investigation of how the microbiota influence immune responses of the host. Studies employing mice lacking microbial communities (germ-free) and mice that have had the composition of their intestinal microbiota altered via antibiotic treatment have revealed that the intestinal microbiota can shape the development, distribution, activation level, differentiation status, and inflammatory profile of dendritic cells, macrophages, natural killer (NK) cells, B cells, CD4 þ T cells, and CD8 þ T cells, both within the gut-associated lymphoid tissue (GALT) and at peripheral sites within the host [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] . An example that illustrates the emerging paradigm of microbiota/immune cell interactions is the role the microbiota has in shaping CD4 þ T-cell differentiation in the lamina propria. Germ-free mice have fewer T helper cell 17 (Th17) CD4 þ T cells in the lamina propria of the small intestine compared with conventionally reared mice [46 ,47 ] . Further, manipulation of the microbiota by oral administration of a specific antibiotic (vancomycin) also results in a reduced percentage of Th17 cells in the lamina propria of the small intestine [48 ] . Consistent with the role of microbiota influencing CD4 þ T-cell differentiation, exposure of mice to a different microbial community known to promote skewing of CD4 þ T cells to a Th17 cell lineage resulted in increased frequencies of CD4 þ interleukin (IL)-17A þ T cells. This induction of Th17 cells was correlated with the increased presence of members of the Bacteroidetes phylum in the microbiota [48 ] . These observations emphasize the possibility that signals from distinct bacterial species have a differential role in influencing the immune cell phenotype within the intestine (Fig. 1) .
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Microbial signals influence DCs and IECs to induce either an immunoregulatory or proinflammatory cytokine environment. This cytokine environment can condition antigen-presenting cells and influence CD4 þ T-cell differentiation within the intestine. DC, dendritic cells; IEC, intestinal epithelial cells; IL, interleukin; MDP, muramyl dipeptide; NOD, nucleotide-binding oligomerization domain; PSA, polysaccharide A; SCFA, short-chain fatty acids; TGFb, transforming growth factor beta; Th, T helper cell; TLR, toll-like receptor; TNFa, tumor necrosis factor alpha; Treg, T regulatory cells; TSLP, thymic stromal lymphopoietin.
Use of the germ-free mouse system has also been important in demonstrating a necessary role for bacteria in the induction and propagation of intestinal inflammation. Several transgenic mouse strains that spontaneously develop intestinal inflammation do not experience disease onset when bred in a sterile, germ-free environment [49] [50] [51] . Furthermore, it has been demonstrated that colitis-inducing bacterial species from a genetically susceptible host can be transferred into wild-type recipients and initiate disease [52] . Thus, certain microbial species are capable of inducing intestinal inflammation in otherwise healthy hosts.
The effects of the intestinal microbiota on the immune system appear to go beyond the intestine and have been shown to influence immune responses at peripheral sites. For example, germ-free mice have a diminished proinflammatory cytokine response to subcutaneous lipopolysaccharide (LPS) injection or ischemic perfusion [53 ,54] . In addition, mice depleted of their intestinal microbiota via antibiotic treatment exhibit an exacerbated allergic response to intranasal ovalbumin (OVA) challenge driven by the Th2 cytokine IL-13 [53 ,54,55] . Furthermore, it was demonstrated that an altered intestinal microbiota was responsible for ameliorating the severity of spontaneous diabetes in MyD88 À/À non-obese diabetic (NOD) mice [56] . This body of literature has been crucial in demonstrating that the intestinal microbiota can influence the immune response in peripheral tissues as well as the intestine.
Microbial recognition in the intestine
The immune system within the GALT must be able to initiate an appropriate immune response against invading pathogens while remaining hyporesponsive when sampling microbial signals from the commensal flora of the intestine. The resulting balance between proinflammatory and immunoregulatory responses is thought to be dependent on the context in which the microbial signals are recognized. Dendritic cells are a key cell type that modulate the immune response within the intestine [57] . Dendritic cells within the intestine are exposed to bacterial products either via M-cell antigen sampling within Peyer's patches or directly by extending dendrites between tight junctions of intestinal epithelial cells (IECs) and into the intestinal lumen [58] [59] [60] [61] . Intestinal dendritic cells are capable of taking up live bacteria and migrating into the mesenteric lymph nodes, thereby exposing resident T and B cells to the microbiota [62] . Dendritic cells express a wide range of pattern recognition receptors (PRRs) that can be activated by microbial products. PRRs expressed by dendritic cells include members of the transmembrane toll-like receptor (TLR) family and the intracellularly residing nucleotidebinding oligomerization domain (NOD) like receptors (NLRs) [63, 64] . Unique pathogen-associated molecular patterns (PAMPs) directly stimulate TLRs or NLRs, leading to activation of the conserved NF-kB, mitogen-activated protein kinase (MAPK), and inflammasome signaling pathways resulting in the expression of a proinflammatory gene profile characterized by cytokines such as IL-12, IL-1b, and type I interferons (IFNs) [65] [66] [67] [68] . However, not all dendritic cell/PAMP interactions result in a proinflammatory response in the intestine. Stimulation of intestinal dendritic cells with the TLR-4 ligand LPS did not result in costimulatory molecule upregulation or IL-12p70 expression as is normally seen with dendritic cells derived from other tissues of the body. Instead, LPS stimulation resulted in elevated IL-10 production by intestinal dendritic cells [69 ,70,71] . In addition, NOD2 signaling has been shown to negatively regulate TLR-2 activation of the NF-kB pathway and thereby attenuate expression of Th1 cytokines [72, 73] .
IECs are directly exposed to the intestinal microbiota and also express TLRs and NOD receptors [64, 74, 75] . Furthermore, microbial products act upon IECs via these PRRs and influence intestinal immune cell development and homeostasis [76,77 ,78,79] . Microbiota-derived signals acting upon IECs can induce an immunoregulatory environment characterized by cytokines such as IL-10, transforming growth factor beta (TGFb), thymic stromal lymphopoietin (TSLP), and IL-25, which modulate dendritic cell, macrophage, and T and B-cell activation (Fig. 1) [35,80,81 ,82-86] . Similar to dendritic cells, PRR activation in IECs by invading pathogens can also elicit a proinflammatory response that is important in initiating the intestinal immune response to infection [87] . Therefore, although cells within the intestinal compartment express TLR and NOD receptors and the ligands for these PRRs are found within intestinal microbiota, the outcome of PAMP/PRR interactions is dependent upon the context in which they occur. Recent work has elucidated several key microbiota-derived signals that can activate TLR or NOD signaling and influence immune cell homeostasis. These can be broadly categorized into signals that have an immunoregulatory effect or signals that augment the proinflammatory immune response.
Signals from the intestinal microbiota can induce an immunoregulatory environment
The intestinal microbiota appears to be integral in inducing an immunoregulatory environment within the intestine. Germ-free mice were reported to have reduced expression of the immunoregulatory cytokine IL-25 in the large intestine [81 ] . Decreased IL-25 was correlated with an increased IL-23 expression and a higher frequency of proinflammatory Th17 cells in the lamina propria of the large intestine. Therefore, although the Th17 cell pool was expanded in the large intestine of germ-free mice, the frequency of T-cell receptor (TCR)b þ Th17 cells was lower in the small intestine of germ-free mice [46 ,47 ] . Thus, it appears that the microbiota can differentially influence immune cells at distinct anatomical locations along the gastrointestinal tract. Compartment-specific influences of the microbiota are consistent with the differences in composition of the microbiota along the length of the intestine. Germ-free mice also exhibit a diminished regulatory T-cell population in the mesenteric lymph nodes that produced less TGFb upon TCR stimulation [37] . These studies suggest that signals from the intestinal microbiota help establish an immunoregulatory state in the intestine. Medzhitov [64] demonstrated that the microbiotaderived signals LPS or lipoteichoic acid (LTA) could influence intestinal immune homeostasis via TLR-4 and TLR-2 signaling, respectively. In this study, mice depleted of their microbiota by antibiotics display exacerbated intestinal inflammation and increased mortality in response to dextran sodium sulfate-induced colitis. However, antibiotic-treated mice, subsequently treated with LPS or LTA, were able to limit intestinal inflammation and recover from chemically induced colitis [88] . The mechanisms by which these TLR ligands had this immunoregulatory effect remain unclear. However, these results indicate that the microbiota can modulate intestinal inflammation, and that a specific microbial signal can orchestrate these immunoregulatory effects in the absence of a living microbiota.
Although TLR ligands have predominantly been shown to be a powerful stimulus to activate a proinflammatory response, under certain conditions, TLR activation is capable of dampening an inflammatory response. In a series of studies, Mazmanian et al. [89, 90 ] demonstrated that signaling through TLR-2 by polysaccharide A (PSA) could induce an environment refractive to inflammation. A unique form of PSA, particular to Bacteroides fragilis, was found to induce an immunoregulatory effect on CD4 þ T cells that was highlighted by an elevated production of the immunoregulatory cytokine IL-10 [91] . Treatment with PSA isolated from B. fragilis prevents the induction of Helicobacter hepaticus-induced colitis, indicating that a single microbiota-derived molecule can influence the immune response within the intestinal environment.
In addition to TLR ligands, the microbiota appears to provide other signaling molecules that modulate the intestinal immune network and limit proinflammatory responses. For example, the NOD2 ligand muramyl dipeptide (MDP) was found to negatively regulate the production of IL-12p40, IL-6 and tumor necrosis factor alpha (TNFa) by dendritic cells in vitro [92] . Furthermore, in-vivo administration of MDP resulted in a diminished proinflammatory cytokine profile of colonic lymphocytes and was able to protect against trinitrobenzene sulfonic acid (TNBS)-induced colitis. Konstantinov et al. [93] have recently described a specific surface layer A protein (SlpA) present on the intestinal bacterial species Lactobacillus acidophilus NCFM that enables bacterial binding to dendritic cells, resulting in the production of IL-10 and inhibition of IL-12p70. Also, butyrate, a SCFA by-product of intestinal bacteria fermentation, has been shown to be the major energy source of colonic epithelial cells and can reduce the expression of TNFa, TNFb, IL-6, and IL-1b in lamina propria lymphocytes potentially via inhibition of the NF-kB pathway [94] [95] [96] . Each of these microbiota-derived molecules is a potential signal through which the intestinal microbiota can induce immune regulation.
Proinflammatory signals from the intestinal microbiota
Although signals from the intestinal microbiota can help establish an immunoregulatory environment, there is also evidence from human and mouse studies linking the microbiota to intestinal inflammatory diseases. As mentioned previously, germ-free and antibiotic-treated mouse studies [46 ,47 ,48 ] have demonstrated the importance of the microbiota in dictating the balance between proinflammatory Th17 cells and regulatory T cells populating the GALT. Atarashi et al. [47 ] attributed this capability to bacterial-derived ATP that preferentially induced Th17 CD4 þ T cells. ATP was shown to act on a population of CD70 high CD11c low accessory cells that expressed P 2 X receptors, a family of ATPbinding receptors. ATP stimulation induced these cells to express IL-6 and IL-23p19, cytokines that can promote Th17 cell development and survival. These findings raise the possibility that, in addition to the influence of distinct anatomical sites along the intestine, microbial signals can have differential immunologic effects depending on whether they are directly recognized by dendritic cells or other cell populations such as IECs.
The microbiota can also augment the immune response and aid in protective immunity against pathogenic infection. For example, Hall et al. [97 ] reported that mice depleted of their intestinal microbiota by antibiotics had diminished IFNg and IL-17 production in the small intestine following infection with the intestinal parasite Encephalitozoon cunniculi. This diminished immune response was correlated with a higher parasite burden compared with wild-type mice. Here, oral administration of the specific TLR ligand CpG, but not LPS, was sufficient to recapitulate the immune response in the antibiotic-treated mice and resulted in parasite clearance in a TLR-9-dependent manner [97 ] . Studies [98] [99] [100] The intestinal microbiota in health and disease Abt and Artis 499 conducted with another intestinal pathogen, Salmonella enterica, found that oral antibiotic treatment increases host susceptibility to Salmonella infection, characterized by increased bacterial translocation and intestinal inflammation. Susceptibility to infection-induced colitis persisted in mice for up to 2 weeks after termination of antibiotic treatment, suggesting that enduring alterations in the composition of the microbiota may be responsible for the inability to limit inflammation [98] . Despite these findings, the mechanisms by which microbial signals can act as an adjuvant during an immune response remain to be elucidated.
Although these studies have uncovered several key molecules that influence intestinal immune cell populations, there is still the question as to how these signals, which are located in the intestine, can influence the systemic immune response. A possible explanation comes from the field of HIV research in which LPS and bacterial DNA have been detected in the serum of HIV-infected patients [101, 102 ] . It has been suggested that depletion of CD4 þ T cells in the intestine following HIV infection eventually leads to intestinal barrier breakdown and microbial translocation of the intestinal microbiota, resulting in microbial signals such as LPS entering the bloodstream. Elevated levels of LPS in the serum of HIV-positive patients correlates with an increased activation phenotype in peripheral blood T cells indicating that the microbial signals may influence the immune response throughout the host [102 ] . In addition, work done by Paulos et al. [103] found that microbial translocation of the intestinal microbiota had an adjuvant effect on the cytotoxic capability of tumorspecific CD8 þ T cells. Combined, these studies suggest that microbial signals derived from bacteria within the intestine can influence immune cell function and susceptibility to immunologic diseases throughout the body.
Conclusion
It is becoming increasingly apparent that the intestinal microbiota can shape immune cell development and function. The impact of the microbiota on the immune system is not uniform as unique signals derived from different bacterial species can have either an adjuvant effect or induce a state of immune hyporesponsiveness. As intestinal microbial signals are capable of promoting such a broad range of immunological outcomes, future studies are likely to focus on identifying the influence of specific microbial signals on immune homeostasis and the molecular mechanism through which these signals elicit their pleiotropic effect. Gaining a better understanding of microbiota/immune system interaction could offer the prospect of manipulating intestinal microbiota to successfully alleviate multiple inflammatory diseases in humans.
